In addition, it is possible to detect mutations related to metastatic events depending on the cancer types analysed as will be discussed in this case report, which describes a patient with brain metastasis and lung cancer that harboured <i>K-RAS</i> mutations both in the brain tumour and in the ctDNA present in the bloodstream. This evidence concerns the gene KRAS and lung carcinoma.